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The developing female genital tract:
from genetics to epigenetics
JULIE MASSÉ#, TANGUY WATRIN#, AUDREY LAURENT, STÉPHANE DESCHAMPS,
DANIEL GUERRIER and ISABELLE PELLERIN*
IGDR, UMR CNRS 6061, Génétique et Développement, IFR 140, Faculté de Médecine, Université de Rennes 1, France
ABSTRACT  The mammalian female reproductive tract develops from the Müllerian ducts which
differentiate, in a cranial to caudal direction, into oviducts, uterine horns, cervix and the anterior
vagina. The developmental processes taking place during this organogenesis are notably under the
control of steroid hormones, such as members of the Wnt and Hox families, which regulate key
developmental genes. At later stages, steroid hormones also participate in the development of the
female genital tract. Chemical compounds homologous to steroids can thus act as agonists or
antagonists in fetuses exposed to them. These so-called endocrine disruptors are nowadays found
in increasing amounts in the environment and may therefore have a particular impact on such
developing organs. Epidemiological studies have revealed that endocrine disruptors have had
drastic effects on female health and fertility during the last decades. Furthermore, these adverse
effects might be transmitted to subsequent generations through epigenetic modifications. Given
the potential hazard of inherited epigenetic marks altering reproduction and/or human health, such
molecular mechanisms must be urgently investigated. This review aims to summarize the cellular
and molecular mechanisms involved in female genital tract development, to highlight key genes
involved in this process and to present epigenetic mechanisms triggered by endocrine disruptors
and their consequences in regard to female reproductive tract development.
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Development of the urogenital system
Relation between urinary and genital tracts
Mammalian genital tract development is closely related to the
urinary system embryogenesis. This relation is ancient in evolu-
tion and phylogenetically well conserved. In simple organisms like
annelids, they both consist in metamerized nephritic tubules
composed of a ciliated funnel oriented towards the coelomic
cavity and connected to a vascularised duct that opens to the
exterior. This system is involved in metabolites and mature genital
cells excretion. In higher vertebrates, the urogenital apparatus
comprises the kidneys, gonads, urinary and reproductive ducts.
The urinary tract embryonic formation is the result of a three steps
process that gives rise to three successive structures emerging
rostrocaudally in the intermediate mesoderm. Nephrotomes first
develop in the cervical part of the embryo; they consist in a ciliated
funnel emerging in the coelomic cavity and in a nephritic tubule
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connected to a common excretory duct (the Wolffian duct, WD).
At this stage, they form a primitive kidney called pronephros which
is not functional. This transitory organ can only be observed in
vertebrate embryos and agnathe larvae (Saxen and Sariola 1987;
Bouchard et al. 2002). Then, while the pronephros is regressing,
the mesonephros develops posteriorly, allowing the WD to grow
in the same direction. This intermediary kidney, comprising a
Bowman capsule and an internal glomerule, is functional and
constitutes the major excretory organ of certain species of fishes
and anamniotes (Saxen and Sariola 1987; Sainio et al. 1997;
Sainio and Raatikainen-Ahokas 1999). In higher vertebrates, an
ultimate kidney structure develops from the fusion of the most
posterior nephrotomes. This so called metanephric kidney or
Abbreviations used in this paper: BPA, bisphenol A; DES, diethylstilbestrol; En,
n days post-coitum; FRT, female reproductive tract; MD, Müllerian duct; Pn,
n days post partum; WD, Wolffian duct.
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metanephros is first connected to the WD, and then to the bladder,
through the ureter. The individualization of the metanephros from
the mesonephros leads to a separation between urinary and
genital tracts; the reproductive tract will later develop from the
mesonephros. While in males, the caudal end of the urethra forms
a common excretory duct with the spermiduct, a total separation
of the female urinary and reproductive tracts occurs, allowing the
internal fertilization and subsequently the development of the
embryo in the uterus (Oppelt et al. 2005a).
As the urinary system develops, another tubular structure
called Müllerian duct (MD) appears (Aamar and Frank 2004). The
MDs grow rostro-caudally, adjacent to the WD, until they join at
the urogenital sinus (Kobayashi and Behringer 2003). At embry-
onic stage 13.5 days post-coitum (E13.5), the WDs and MDs
which are respectively the anlagen of the male and female genital
tracts, are both present in males and females (Jacob et al. 1999;
Carroll et al. 2005). After sexual differentiation, the MDs regress
in males and the WDs differentiate into male genital tract. In
females, the mesonephric ducts regress and the MDs give rise to
the oviducts, uterus, cervix and vagina.
Müllerian duct formation
The embryonic origin of the MDs has been a controversial
issue for several years. Although they develop after pronephros
resorption, it has nevertheless been suggested that the MDs were
pronephretic derivatives. Indeed, some authors initially supported
the idea that the anterior part of the oviducts was derived from
fused nephrotomes remaining in the coelomic epithelium as small
secondary ducts (Wrobel et al. 2002). However, it is now well
established that MD formation is initiated in the cervical part of the
intermediate mesoderm of the mammalian embryo (E11.75 in
mice) by the invagination of the coelomic epithelium (Kobayashi
et al. 2004; Orvis and Behringer 2007), as illustrated in Fig. 1. The
mechanism by which invaginating cells acquire an MD fate
remains unclear, although Wnt4 expression in the coelomic
epithelium or the mesonephros seems to be necessary for MD
initiation (Vainio et al. 1999). After initiation, the MDs elongate
posteriorly, in close contact with the WDs, until they join at the
urogenital sinus (Basile and De Michele 2001b). More precisely,
a recent study from Orvis and Behringer, clearly showed that the
Müllerian epithelium, at its most posterior end, is in physical
contact with the Wolffian duct epithelium and is separated from
the coelomic epithelium only by a basement membrane (Orvis
and Behringer 2007). Based on genetic markers, the same study
revealed that, in spite of its epithelial morphology, MD epithelium
expresses mesenchymal markers and could thus be considered
as a meso-epithelium tissue (like the coelomic epithelium which
also expresses epithelial and mesenchymal markers) (Orvis and
Behringer 2007). Furthermore, it has been demonstrated that WD
experimental interruption leads to MD incomplete formation,
highlighting the link between Wolffian and Müllerian ducts
(Gruenwald 1941). More recent data have allowed to precise this
information. Indeed, it seems that the first phase of MD develop-
ment is WD-independent, whereas the close contact with the
Wolffian duct is essential for Müllerian duct elongation (Vainio et
al. 1999; Kobayashi et al. 2005; Orvis and Behringer 2007). The
origin of Müllerian cells along the duct was still not clear until
recently. Indeed, two hypotheses were proposed. The first one
was in favour of Wolffian duct cells contribution to Müllerian duct
formation (Balfour 1879), whereas the second supported that the
WD just acted as a guide (Dohr et al. 1987b). Very recent data
ruled out the hypothesis of the involvement of Wolffian duct cells
as source of Müllerian duct epithelium (Dohr et al. 1987a; Guioli
et al. 2007; Orvis and Behringer 2007). By lineage-tracing of
Fig. 1. Model for Müllerian duct development. At E11.75, after a
subset of coelomic epithelium cells (represented in green) are specified,
they invaginate in the intermediate mesoderm. Then, the invaginating
cells form the Müllerian duct (M, represented in pink). Anteriorly, the
funnel is opened in the abdominal cavity, and caudally, the growing tip
extends to and contacts the Wolffian ducts (W, represented in blue) at
E12.0. A phase of elongation allows the Müllerian duct to elongate
posteriorly in very close contact with the Wolffian duct. As soon as the
Müllerian duct growing tip has deposited cells and elongated caudally,
the physical contact between the ducts is lost by the appearance of
mesenchymal cells around the Müllerian duct epithelium. At E13.5, the
two Müllerian ducts reach the urogenital sinus and fuse together.
Developmental stages indicated in this figure correspond to mice stages.
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coelomic epithelium, in chick and mice explants, the authors
showed that a discrete population of coelomic epithelium cells,
probably located in the transition area between pronephros and
mesonephros, segregates and gives rise to the entire anlagen of
the Müllerian duct epithelium (Guioli et al. 2007). In addition, the
origin of Müllerian ducts was corroborated by another approach
using recombinant transplant cultures (Orvis and Behringer 2007).
While no cell contribution from the Wolffian ducts is required for
Müllerian duct formation, these cells play nevertheless a role in
this process by sending paracrine signals (Carroll et al. 2005).
In addition to the demonstration of the origin of Müllerian duct
cells, both groups of authors have described the cellular pro-
cesses leading to MD elongation and mesenchyme formation
(Guioli et al. 2007; Orvis and Behringer 2007): they showed that,
in both chick and mouse, the full length Müllerian duct epithelium
possesses BrdU and histone H3 positive cells, suggesting that the
MDs can extend dependently of widespread cell proliferation
along the developing duct. In addition, by removing the rostral part
of the Müllerian duct on mesonephros explants, it has been
demonstrated that the posterior tip cells of the duct are sufficient
for laying the foundation of the forming Müllerian duct (Orvis and
Behringer 2007). Concomitantly to Müllerian epithelium elonga-
tion, a spatial organization of mesenchyme surrounding cells
takes place and physically separates the Wolffian and Müllerian
ducts. The mechanism by which these surrounding mesenchymal
cells get a Müllerian fate is still not clear. In fact, the Müllerian duct
mesenchyme seems to derive from in situ mesonephros mesen-
chyme as well as local delamination of the coelomic epithelium
cells situated along the length of the mesonephros (Guioli et al.
2007).
Differentiation of the Müllerian duct
The Wolffian and Müllerian ducts are discrete primordia which
temporarily coexist in undifferentiated embryo until genetic sex
triggers differentiation of either ovaries or testes. In males, MDs
regress due to the sexual dimorphic expression of the anti-
Müllerian hormone (AMH), also known as Müllerian-inhibiting
substance (MIS), a member of the transforming growth factor-β
(TGF-β) family, secreted by the Sertoli cells of the foetal testis
(Josso et al. 1993). In addition, testosterone production by Leydig
cells, allows androgen-dependant growth and differentiation of
Wolffian ducts into epididymides, vas deferens and seminal
vesicles (Hannema and Hughes 2007). In females, in absence of
testicular hormones, Müllerian ducts differentiate into Fallopian
tubes, uterus, cervix and upper part of the vagina while the
Wolffian ducts degenerate (Jost 1953).
At the end of the elongation step, the growing tips of the MDs
converge and join at the urogenital sinus (Orvis and Behringer
2007). The Müllerian tubules then fuse and form a one-luminar
tube, the utero-vaginal duct, which will give rise to the upper
vagina, cervix and uterus. The anterior non-fused region of the
MD differentiates into oviducts and infundibulum. The morphol-
ogy of mammalian uterus markedly varies between species,
depending on the width of the ducts fusion. For instance, uterus
is duplex in most rodents, generally bicornuate in big quadrupeds
and simplex in most primates, including humans (Kobayashi and
Behringer 2003). Although still controversial, it is generally admit-
ted that the lower vagina is a derivative of the urogenital sinus.
However its differentiation requires an induction mechanism by
the MD (Drews et al. 2002; Kobayashi et al. 2005). Data obtained
from studies on human malformative syndromes clearly argue in
that direction. Indeed, the Mayer-Rokitansky-Küster-Hauser
(MRKH) syndrome is a genetic disease that affects notably the
development of inner genital tract (Basile and De Michele 2001a)
(Morcel et al. 2007). These women lack Müllerian derivatives
(uterus, upper vagina and optionally oviducts) but possess the
lower part of the vagina, showing that upper and lower parts have
different embryologic origins (Oppelt et al. 2005b). At birth, the
female genital tract has undergone a regional morphologic
specialisation that differentiates oviducts, uterus, cervix and
upper vagina but it is still composed of simple structures that will
acquire a full maturation aspect after birth and until puberty.
Maturation of Müllerian ducts
The MD maturation proceeds in three steps: 1) region specific
Müllerian duct epithelium differentiation, 2) formation and organi-
zation of endometrium and myometrium, 3) uterine adenogenesis.
Firstly, the single-layered epithelium acquires different mor-
phologies and cyto-architectures along its anterior-posterior axis.
While the uterine epithelium is composed of simple columnar
epithelial cells, the posterior cervix and the vaginal epithelia are
made up with of stratified squamous cells and the oviducts
epithelium possesses of ciliary and secretory cells. This process
seems to occur perinatally since, at E16-18, the oviductal, uterine,
cervical and Müllerian vaginal epithelial cells are morphologically
undistinguishable (Komatsu and Fujita 1978; Kurita et al. 2001).
Distinct markers then appeared in mice at around 1-3 days
post-partum (P1-3), and as regional patterning of epithelial differ-
entiation takes place in the uterus, cervix and Müllerian vagina
(Kurita et al. 2001). Oviductal epithelium ciliary cells differentiate
at P5-10 and active secretory cells are observed from P23
(Komatsu and Fujita 1978). At the utero-vaginal level, the Müllerian
duct epithelium undergoes these region-specific morphogenetic
changes under mesenchymal cells paracrine influence (Cunha
1975;1976b;a). Indeed, heterotypic recombinant assays have
demonstrated that uterine and Müllerian vaginal epithelia are both
able to undergo either uterine or vaginal differentiation when
induced by uterine or Müllerian vaginal mesenchyme, respec-
tively. This characteristic is however stage-dependent: epithelial
cells are the most responsive to mesenchyme signals at around
P2-P5 but lose this competence by P9 (Cunha 1976b). At P10,
only a subset of epithelial cells has kept some plasticity (Kurita et
al. 2001). Uterine mesenchymal inductive activity has been shown
in P2 up to P7 neonates whereas vaginal stroma keeps its
inductive activity from 2 up to 150 days after birth (Cunha 1976b).
Subsequently, in the developing uterus, like in many other organs
(intestine, bladder, etc.), mesenchymal cells in close proximity to
the epithelium differentiate into fibroblasts, to form the en-
dometrium, whereas the most distant ones differentiate into
smooth muscle, so forming the myometrium (Brody and Cunha
1989). It has been further demonstrated that myometrium differ-
entiation and spatial organisation require the epithelium which
can therefore be considered as a key mesenchymal inducer for
endometrial/myometrial segregation and subsequent formationn
(Cunha et al. 1989; Cunha et al. 1992).
The female genital tract development ends with adenogenesis,
i.e. the formation of uterine glands, which is the paroxysm of its
functional differentiation. These glands are essential to later
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survival and development of the conceptus by secreting histotrophic
substances. Uterine adenogenesis involves differentiation and
budding of glandular epithelium from luminal epithelium, penetra-
tion of uterine stroma by tubes of glandular epithelium and
extensive branching and coiling of glandular epithelium (Gray et
al. 2001). The timing of uterine adenogenesis is highly variable
among mammalian species. In mice, it begins around P5 by
epithelial invagination of glandular epithelium into the luminal
epithelium (Brody and Cunha 1989); and completion is observed
by P7 (Branham et al. 1985). This process seems to be governed
by site-specific alterations in cell proliferation and movement, as
well as by paracrine, cell-cell and cell-extracellular matrix interac-
tions, and specific endocrine-, paracrine- and juxtacrin-acting
factors and receptors (Gray et al. 2001).
Molecular genetics of Müllerian duct development
Most of the genes known to be essential for MD embryonic
development have been characterized either by description of
Human syndromes affecting the female reproductive tract (FRT)
formation, regression and differentiation or by studies of knocked-
out mice (Table 1 and Fig. 2). Analysis of the molecular and
cellular mechanisms of MD development depicts an emergent
genetic cascade for this process (Kobayashi and Behringer
2003).
Early onset of Müllerian ducts
As aforementioned, the initial steps of MD formation in both
sexes briefly consist in invagination of coelomic epithelium and
caudal elongation towards the urogenital sinus. These two mecha-
nisms depend on correct expression of various transcription
factors and signalling molecules. As previously described, the
elongation phase, as well as further maintenance of MD, seems
not only to depend on the intrinsic nature of the MD, but also to
require the presence of WD (Roberts et al. 2002). As a conse-
quence, genes involved in WD development are of critical impor-
tance for the subsequent onset of MD. Amongst factors required
for FRT development, Lim1 (a.k.a. Lhx1), Pax2, Emx2, Wnt4,
Wnt9b, Tcf2, Dach1 and Dach2 seem to be essential for the initial
biphasic process of MD formation and are therefore detailed
below.
Lim1, a homeodomain-containing transcription factor, shows a
dynamic expression pattern in the epithelium of the developing
MD, beginning at E11.5 in the mouse. This suggests a role for
Lim1 in the very early steps of MD formation. Indeed, Lim1-null
mutant mice display complete absence of mesonephric- and
paramesonephric-derived structures, a phenotype consistent with
the expression of the gene in the epithelium of both sexual ducts
(Kobayashi et al. 2004). Furthermore, specific inactivation of Lim1
in the WD epithelium, causing its degeneration, leads to impaired
development of MD but does not affect their initial formation,
highlighting the WD-dependent processes of MD elongation and
maintenance but not initiation (Kobayashi et al. 2005). Pax2, a
member of the paired-box gene family encoding transcription
factors, is also expressed in the epithelium of the Wolffian and
Müllerian ducts. This gene, involved in multiple developmental
processes, appears to be essential for the development of the
epithelial components derived from intermediate mesoderm. In-
deed, Pax2-null mutant mice, which die perinatally due to absent
kidneys, have neither Wolffian nor Müllerian derivatives (Torres et
al. 1995). Nevertheless, unlike the phenotype observed in Lim1-
null mutant mice, both sexual ducts initially form in Pax2-null
 Spatio-temporal expression of genes during FRT development   
Gene Early1  Late2 Adult (sexual cycle) Phenotype in KO female mice References 
Lim 1 CE, WE, ME ME NA No FRT Kobayashi, 2004 
Pax2 CE, WE, ME ME Oviducts and proliferative 
epithelium No FRT 
Torres, 1995 
Tong, 2007 
Emx2 WE, ME MMET Endometrial development No FRT Myamoto, 1997 
Wnt4 CE, MM Restricted to uterine 
mesenchyme Dynamic expression No FRT 
Vainio, 1999 
Miller, 1998b  
Wnt5a MM, ME MM Dynamic expression Defective posterior growth of MD. No uterine glands Miller, 1998b Mericskay, 2004 
Wnt7a ME ME Dynamic expression Posteriorization of genital  tract. No uterine glands 
Miller & Sassoon, 1998  
Parr, 1998; Carta & Sassoon, 2004 
Wnt9b WE (*), NE in MD WE (until E14.5), NE in MD NE Absent uterus and upper vagina Carroll, 2005 
RAR α,β,γ  NA Combined mutants: various degrees of affection  Mendelsohn, 1994 
Dlgh1 WE (*) NE NA Cervix and vagina aplasia Iizuka-Kogo, 2007 
β-catenin All compartiments Hypotrophic uterine horns + defective oviduct coiling. Myogenesis to adipogenesis switch (**) 
Arango, 2005 
Deutscher, 2007 
Hoxa10 Homeotic transformation of the anterior part of the 
uterus to an oviductal morphology Benson, 1996 
Hoxa11 Partial anteriorization: hypoplastic uterus,decreased 
endometrial glands. Gendron, 1997 
Hoxa13 (***) 
Colinear expression along the A/P axis Steroid-dependent 
expression 
Agenesis of the caudal portion of MD. Warot, 1997 
 
TABLE 1
GENES INVOLVED IN THE DEVELOPMENT OF FEMALE GENITAL TRACT
MD: Müllerian duct; ME: Müllerian epithelium; WD: Wolffian duct; WE: Wolffian epithelium; CE: coelomic epithelium; MMET: Müllerian Mesenchyme-Epithelium Transition; FRT: Female Reproductive
Tract; NA: not available; NE: not expressed.
1 Early refers to determination, invagination and elongation steps of MD. 2 Late corresponds to E13.5 (time of MD regression in the male) to puberty. * Specific WD genes are indicated since MD
growth initially depends on the presence of WD. ** Targeted knock-out, efficient from E15.5. *** Compound Hoxa13+/-;Hoxd13-/--mutant females display severe urogenital and rectal anomalies (Warot,
1997) whereas Hoxd13-/--mutant female are still fertile (Dollé et al. 1993).
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embryos but degenerate soon after. In addition, the homeobox-
containing gene Emx2, is expressed in the epithelial components
of the urogenital system and plays a major role in the development
of this organ. Similarly to Pax2 mutants, both sexes of homozy-
gous null mice for Emx2 display complete absence of urogenital
tract and die soon after birth (Miyamoto et al. 1997). Nevertheless,
WD develops normally at E10.5 in these mice but degenerates the
day after and, as expected, no MD is observed later. Finally, the
POU domain-containing TCF2 gene (formerly v-HNF1 or HNF-
1beta) has been shown to be expressed in many organs during
development (Coffinier et al. 1999) and seems to play a general
role in epithelial differentiation (Coffinier et al. 1999; Kolatsi-
Joannou et al. 2001). Expression of this gene is particularly
noticeable from the earliest steps of urogenital tract formation up
to adult stage in the mouse model (Coffinier et al. 1999; Reber and
Cereghini 2001). It was originally found associated with MODY-
type diabetes (Horikawa et al. 1997) and with diabetes mellitus,
renal cysts and other renal developmental disorders (Bingham et
al. 2001; Kolatsi-Joannou et al. 2001). Interestingly, genital mal-
formations such as bicornuate uterus (Bingham et al. 2002),
uterus didelphys (Bingham et al. 2002) and Müllerian aplasia
(Lindner et al. 1999) were also found together with renal anoma-
lies in patients showing a defective gene, tending thus to show a
major role of the TCF2 gene during uro-genital development.
Transcriptional co-factors such as Dach1 and -2 seem to also take
place in the molecular cascade of MD formation. Whereas inac-
tivation of each corresponding gene does not appear to affect this
pathway, combined knock-out results in drastic defect of Müllerian
derivatives, tending to show a functional redundancy of these
factors (Davis et al. 2008).
In addition to the key role of the above homeodomain transcrip-
tion factors in the early steps of MD formation, some signalling
molecules have been shown to be involved in this process.
Amongst them, Wnt9b and Wnt4, two members of the Wnt gene
family encoding secreted glycoproteins, homologues to the Droso-
phila segment polarity gene wingless, are crucial paracrine fac-
tors. In mice, Wnt9b is expressed in the WD epithelium from E9.5
to E14.5 in both sexes and seems to be necessary for MD
extension (Carroll et al. 2005). Interestingly, the phenotype of
Wnt9b mutants can be rescued by activation of Wnt1 within the
WD, identifying the canonical Wnt pathway as a determinant
signalling process in Müllerian ducts elongation. Another member
of the family, Wnt4, is expressed in mesenchymal cells surround-
ing the newly formed MD on E12.5 in the mouse. Wnt4-null female
mice exhibit a complete absence of FRT and, strikingly, are
masculinised, probably due to ectopic activation of testosterone
biosynthesis as initially hypothesized (Vainio et al. 1999; Heikkila
et al. 2005). In fact, no Müllerian structures are observed both in
male and female mutant mice on E11.5, before normal regression
of MD takes place in the male. Thus, this reversal of sexual
development in mutant female indicates a requirement for Wnt4
in the initial steps of MD formation in both sexes but also for the
suppression of male differentiation pathway in female gonad.
Incidentally, a mutation in the Wnt4 gene was discovered in a 46,
XX woman presenting a somewhat similar phenotype: complete
absence of MD-derived structures and clinical signs of androgens
excess (Biason-Lauber et al. 2004). Interestingly, Wnt4 and Fgf9
seem to constitute mutual antagonistic signals in the bipotential
gonad, regulating gonadal differentiation into female or male
pathway by imbalance between them (Kim et al. 2006).
Another well-studied signalling molecule in the context of
embryonic development is retinoic acid (RA), a morphogen de-
rived from vitamin A. RA seems to be particularly involved in
antero-posterior patterning both along the body axis and in
developing limb bud (Dreyer and Ellinger-Ziegelbauer 1996;
Robert and Lallemand 2006). Compound null mutations of its
cognate receptors (RARs and RXRs) lead to a broad range of
developmental abnormalities, among which severe defects of the
urogenital system (Mendelsohn et al. 1994). More precisely,
RARαβ2 double mutants lack identifiable MD in E12.5, a pheno-
type not imputable to a defect in WD formation, making RA
signalling a specific pathway required to ensure the correct
formation of MD. Similarly, abnormalities of the urinary and
genital tracts have been recently described in Dlgh1-null mutant
mice in both sexes (Iizuka-Kogo et al. 2007). The most interesting
defect here is the aplasia of the uterine cervix and vagina due to
defective lateral fusion and impaired caudal elongation of MD
(Iizuka-Kogo et al. 2007). At the present time, no relation between
retinoic acid and Dlgh1 gene has been established. Finally, a
- Amhr2
- Mmp2
- Bmpr1a
- Alk2
-Sfrp2/5
- Hoxa10-a13;Hoxd13
- Wnt7a
- Wnt5a
- Mesenchyme-derived
β-catenin
- p63
MD differentiation MD regression
Male and female genital tract anlagen
in sexually indifferent stage embryo
Pax2 Emx2 Lim1 Dach1/2 Wnt4 Hnf1β
Wnt7a
♀
-Amh
♂
+Amh
Fig. 2. Genes involved in the regression or development of the
Müllerian ducts. At the so-called sexually indifferent stage (bipotential
gonad), both male and female reproductive duct primordials co-exist.
Sexual differentiation takes place according to the genetic sex of the
embryo, determining its gonadal status and consequently allowing the
differentiation into male or female reproductive organs. In female em-
bryos, in the absence of specific male hormones, the WDs degenerate
while the MDs ducts develop. In male embryos, the MDs degenerate and
the WDs give rise to the male genital tract. Key genes involved in such
processes are indicated on the figure.
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requirement of PI3K/AKT signalling pathway for MD tip elongation
has been uncovered (Fujino et al., 2008), highlighting the intricacy
of multiple signalling pathways for MD development.
Regression of Müllerian ducts in the male
As mentioned earlier, both male and female reproductive duct
primordials coexist at the so-called sexually indifferent stage.
Subsequently, sexual differentiation takes place according to the
genetic sex of the embryo, determining its gonadal status and
consequently allowing the differentiation into male or female
reproductive organs. In female embryos, the absence of andro-
gens seems to be sufficient to cause the degeneration of the WD,
whereas regression of MD in male embryos is an active process
mediated by AMH solely secreted by the foetal testis.
Molecular and cellular studies, mainly in the mouse, have
shown that AMH exerts its effect on MD through a paracrine
mechanism, by binding to its type II receptor (AMHRII). This latter
is initially expressed in the coelomic epithelium of the mesoneph-
ros, prior to regression (Zhan et al. 2006). Binding of AMH to
AMHRII induces the AMHRII-expressing cells to migrate into the
area adjacent to the MD and eventually around the MD at ~E15.5,
corresponding thus to an epithelial-to-mesenchymal transition. In
the female, in absence of AMH, AMHRII expression remains
located in the coelomic epithelium at least until stage E15.5 (Zhan
et al. 2006). Amh- or AmhrII-mutant male mice show an identical
phenotype: they exhibit a morphologically normal male reproduc-
tive system but are infertile because of the persistence of a
complete FRT blocking sperm passage (Behringer et al. 1994;
Mishina et al. 1996). Mutations in AMH or AMHRII genes have
been reported in patients affected by Persistent Müllerian Duct
Syndrome type I and type II respectively (Di Clemente and Belville
2006). These evidences tend to show that AMHRII is probably the
unique receptor of type II mediating AMH signalling. In the mouse,
Bmpr1a (a.k.a. Alk3) has been identified as a type I receptor,
necessarily associated to AmhrII to mediate Amh-induced regres-
sion of Müllerian derivatives (Jamin et al. 2002). It is noteworthy
that other Tgf-β family type I receptors can transduce Amh signal
in absence of Bmpr1a (Clarke et al. 2001; Jamin et al. 2003).
Interestingly, Alk2 (a.k.a. Acvr1) seems to mediate Amh signalling
by inducing migration of AmhrII-expressing epithelial cells from
the coelomic epithelium into the MD mesenchyme, accounting for
the sexually dimorphic pattern of AmhrII expression during the
regression (Zhan et al. 2006). According to their spatiotemporal
expression pattern, Alk2 and Bmpr1a type I receptors are though
to act sequentially in MD regression. Moreover, an epithelial-
derived Wnt7a signal is required to induce or to maintain AmhrII
expression in the Müllerian mesenchyme of both sexes, and thus
responsiveness to Amh signalling. Indeed, Wnt7a-deficient mice
do not express AmhrII in the ductal mesenchyme and are infertile
due to persistent MD in the male and abnormal morphogenesis of
the oviduct and uterus in the female (Parr et al. 1998; Parr and
Mcmahon 1998). The direct effect of Wnt7a inactivation was
corroborated by the description of β-catenin/Tcf4 complex bind-
ing onto AmhrII promoter to activate the gene (Hossain and
Saunders 2003). These data highlight the multiple roles of Wnt
signalling in the molecular cascades triggering sexual develop-
ment. One of the earliest events following Amh signalling, but prior
to MD regression seems to be Sfrp2 and -5 gene upregulation.
However single or combined inactivation of either gene does not
lead to any overt anomaly of the reproductive tract development,
suggesting that other members of the Sfrp gene family may
redundantly be involved in this process (Cox et al. 2006).
Regression of MD is a cranial-to-caudal process achieved by
both apoptosis of epithelial cells and epithelio-mesenchymal
transition. A positive correlation has been found between the
expression pattern of AmhrII and β-catenin cytoplasmic accumu-
lation in the peri-Müllerian mesenchymal cells and seems to
follow the wave of apoptosis spreading chronologically along the
cranio-caudal axis (Allard et al. 2000). Furthermore, β-catenin co-
localizes with Lef1 (another member of the nuclear TCF/LEF
family) in the nucleus of mesenchymal cells treated with Amh, and
therefore might alter gene expression and cell fate, making β-
catenin/Lef1 complex a possible mediator of Amh action. Indeed,
Allard and colleagues have observed that apoptosis of epithelial
cells occurs only after disruption of the MD basement membrane
and is followed by an entry of healthy epithelial cells into the
mesenchymal compartment where they are subject to epithelio-
mesenchymal transformation (Allard et al. 2000). One of the
putative targets of Amh signalling is the Matrix metalloproteinase
2 gene (Mmp2). This gene is expressed in a sexually dimorphic
pattern with an upregulation in the male Müllerian mesenchyme
during regression; this male-specific expression pattern is lost in
Amh-null mutant mice (Roberts et al. 2002). Additionally, inhibi-
tion of Mmp2 protein activity blocks MD regression in vitro and is
correlated with a decrease of apoptotic cells in the MD epithelium.
Although Mmp2-null mutant mice develop a normal urogenital
tract, probably due to redundancy with other gene (s) (Oppelt et
al. 2005b), Mmp2 remains a putative actor of Amh-induced
regression (Itoh et al. 1997). More recently, Wilms’ tumour sup-
pressor gene (Wt1) has been described as another regulator of
AmhrII expression (Klattig et al. 2007), providing a novel function
for Wt1 in the process of sexual development.
Differentiation of Müllerian ducts
In the female foetus, the differentiation of MD along the antero-
posterior (A-P) axis depends on local inductive interactions be-
tween the MD epithelium and the surrounding mesenchyme. The
correct regionalization of FRT, i.e. acquisition of tissue identity in
cervix, uterus and vagina, relies on spatiotemporally regulated
interactions between transcription factors and signalling mol-
ecules. Most of the genes acting to determine Müllerian cell fate
and thus the proper MD identity are still expressed throughout
differentiation. Amongst these genes, homeogenes such as Hox
genes play a crucial role in specifying cell characteristics along
the A-P axis.
The homeobox (Hox) genes belong to a large family of 39
genes organized in four clusters, Hoxa to Hoxd (HOXA-D in
Human), each on a different chromosome. These major develop-
mental genes are involved in patterning the animal body axis by
providing positional identity through the molecular “Hox code”,
emerging from highly complex spatiotemporal combinations of
Hox proteins (Hombria and Lovegrove 2003). Some members of
the Abdominal-B (Abd-B) like Hox gene family, Abd-B Hoxa9 to 13
and Hoxd9 to 13, are expressed in partially nested patterns in the
mesenchyme of the developing MD, defining a specific Hox code
along the A-P axis (Dollé et al. 1991; Taylor et al. 1997). Evidence
of their roles was provided, particularly by in vivo inactivation of
Hoxa10, Hoxa11, Hoxa13 and Hoxd13 genes in the mouse, that
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led to region-specific alterations of the reproductive tract. Hoxa10-
null mutant mice exhibit abnormal utero-tubular junction and
uterine epithelium and an anterior homeotic transformation of the
upper part of the uterus into oviduct-like structure (Benson et al.
1996). In Hoxa11-deficient mice, the uterus is thinner and shorter
than normal and endometrial glands have not developed, sug-
gesting an anteriorized phenotype (Gendron et al. 1997). More-
over, replacement of the homeodomain of Hoxa11 by that of
Hoxa13 results in a posterior homeotic transformation of the
uterus into cervix- and vagina-like structures (Zhao and Potter
2001). Besides, Hoxa13-null mice show agenesis of the distal
portion of the MD, indicating a role for Hoxa13 not only in the
differentiation but also in the formation of MD (Warot et al. 1997).
Subsequently, mutations in the HOXA13 coding region have been
shown to cause Hand-foot-genital syndrome (HFGS) in Human,
characterized by hands and feet defects, hypospadias in males,
Müllerian duct fusion defect in females and urinary tract malfor-
mations in both sexes (Mortlock and Innis 1997; Goodman et al.
2000).
Despite its involvement during MD regression in the male,
Wnt7a is also required for correct patterning of the murine FRT.
Initially expressed throughout the MD epithelium, Wnt7a expres-
sion becomes postnatally restricted to the oviductal and uterine
epithelium, declining in the vaginal epithelium (Miller et al. 1998b).
Loss of Wnt7a expression in the differentiating MD results in
partial homeotic transformation of the oviduct to uterus and of the
uterus to vagina (Miller and Sassoon 1998). Since Wnt7a is not
required to induce Hoxa gene maintenance, Wnt7a and Hoxa
genes are likely acting in parallel pathways during FRT develop-
ment. Indeed, a combinatorial regulation by Hox and Wnt genes
probably occurs in most organogenesis and therefore during FRT
development (for a review, see Bondos 2006). Moreover, Wnt7a
mutant uterus in adult presents an atrophic aspect due to postna-
tal uterine growth failure, a phenotype partly related to the role of
Wnt7a as a suppressor of cell death in the FRT (Carta and
Sassoon 2004). In addition, the absence of oviduct coiling in the
Wnt7a-null mice has been reproduced by specific inactivation of
β-catenin in the MD mesenchyme using an Amhr2-cre mouse
line, without any observed alteration in Wnt5a and Wnt7a expres-
sion patterns (Deutscher and Hung-Chang Yao 2007). This defect
on oviduct differentiation is accompanied by an overall hypotrophic
aspect of uterine horns, a phenotype correlated with a decreasing
cell proliferation in both the epithelium and the mesenchyme of
the Müllerian derivatives. In the end, deletion of β-catenin directed
by the Amhr2-cre transgene leads to adipose tissue deposition in
the uterine wall in adult, probably due to cell fate switch from
myogenesis to adipogenesis (Arango et al. 2005; Deutscher and
Hung-Chang Yao 2007), without any ovarian phenotype. Never-
theless, recent in vitro studies have uncovered the requirement of
β-catenin for normal ovarian steroidogenesis (Hernandez-Gifford
et al. 2009).
Given the specific expression of Wnt7a in the luminal epithe-
lium of the uterus (Miller et al. 1998b), the phenotype of Wnt7a-
null mutant mice implies crucial paracrine interactions between
uterine epithelium and stromal cells. Wnt5a, a component of the
non-canonical Wnt signalling pathway, that is expressed in mes-
enchyme of the uterus, cervix and vagina (Miller et al. 1998b), is
an actor of such interactions. Indeed, Wnt5a is required for proper
development of the posterior region of FRT and for uterine
adenogenesis (Mericskay et al. 2004). Therefore, involvement of
Wnt7a and Wnt5a for glandular genesis in the uterus highlights
the necessary cooperation between epithelium- and stroma-
derived signals during the essential process of cyto-differentia-
tion. In this context of reciprocal interactions, p63, a homologue
of p53 tumour suppressor gene, is considered as an identity
switch for MD epithelial differentiation into uterine or cervicovaginal
cell fate (Ince et al. 2002; Kurita et al. 2004). Besides, the
homeodomain transcription factor Msx2, promotes normal vagi-
nal epithelial differentiation and, interestingly, seems to be in-
volved in regression of the caudal region of WD in females by
promoting apoptosis (Yin et al. 2006).
In conclusion, differentiation of MD into a functional reproduc-
tive tract relies on a complex genetic cascade wherein coopera-
tion between Wnt and Hox genes is fundamental for correct
patterning and maturation of the FRT. It is noteworthy that many
of the developmental genes presented above, especially Hox
genes, are also regulated by steroid hormones during both
embryogenesis and adulthood (Daftary and Taylor 2006). The
role of this endocrine regulation in the reproductive tract is now
well established during embryonic development but appears to be
also essential in adult developmental-like processes such as
menstrual cycle, embryo implantation and pregnancy.
Studying the consequences of prenatal or perinatal exposure
to endocrine disruptors such as diethylstilbestrol (DES) gives new
insights on hormonal regulation of these genes during critical
periods of FRT development and may be useful to address the
question of epigenetic regulations of Hox genes, an extensively
studied research field in recent years.
What about epigenetics?
Epigenetics and environment
The term epigenetics refers to the overall molecular phenom-
enon which is heritable from parents and that regulates gene
expression without any alteration of the genomic DNA sequence.
These heritable epigenetic changes include DNA methylation,
post-translational modifications of histones tails (acetylation,
methylation, phosphorylation,..) and chromatin remodelling. The
epigenome is the set of epigenetic prints present in a given
genome, at a given time and in a given cell type.
Most of the studies on epigenetic regulation have shown that
environment can play an important role in this respect. Indeed,
both environmental chemicals and toxins have recently been
shown to alter DNA methylation patterns, resulting in epigenetic
phenotypes (Cisneros 2004; Anway et al. 2005).
Several studies have shown that, during critical periods of
differentiation, exposure to low environmentally relevant doses of
some chemicals, may alter developmental programming. In par-
ticular, two studies demonstrated that xenobiotic chemicals such
as tributyltin present in PVC plastics as well as some fungicides,
alter normal development and homeostatic control over adipo-
genesis and energy balance, leading to obesity (Grun and
Blumberg 2006; Tabb and Blumberg 2006). Moreover, recent
works on mice by Newbold and collaborators, support the idea
that a brief exposure to environmental chemicals, especially
those with estrogenic activity, can increase body weight in corre-
lation with age (Newbold et al. 2007b; Newbold et al. 2007c).
Precisely, treatment of females with diethylstilbestrol does not
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affect the body weight during the time of exposure, but provokes,
later on, an increase of the body weight associated with an
augmentation of body fat. In addition, exposure of adult animals
to metals such as cadmium or nickel, has been associated with
tumorigenesis. In fact, these metals seem to interact with the
epigenome and induce carcinogenic effects through abnormal
DNA methylation (Salnikow and Costa 2000; Poirier and Vlasova
2002).
Among harmful chemicals, the so-called endocrine disruptors
have been described to present strong effects on the develop-
ment of organisms. Indeed, various natural or synthetic mol-
ecules can interfere with the endocrine system through the
binding to members of the intracellular steroid receptors family.
This interference ultimately disturbs the normal function of tissues
and organs, in particular those of the reproductive tract. Exposure
to endocrine-disrupting chemicals present in the environment has
been reported to cause many disorders in mammals like abnor-
mal thyroid and immune function, alteration of the developing
reproductive tract such as de-masculinization and feminization of
males, associated with decreasing fertility. These adverse effects
were reported for multiple chemicals such as industrial waste and
pesticides (reviewed in Colborn et al. 1993).
Recently, several lines of evidence have tended to show that
epigenetic adaptations, in response to in utero nutritional and
environmental factors, play an important role in developmental
plasticity and diseases susceptibility. Waterland and collabora-
tors have demonstrated that the epigenetic gene regulation of the
imprinted gene Igf2 may be influenced by early post-natal nutri-
tional diet in the mouse model. Indeed, in normal environmental
conditions, the Igf2 gene is expressed from the paternal allele
whereas the maternal gene is repressed by imprinted silencing.
When a methyl-donor deficient diet is administered to animals for
60 days post-weaning, a paternal hypomethylation of the gene is
observed, in correlation with a significant loss of imprinted regu-
lation of the Igf2 gene (Waterland et al. 2006). Therefore, nutrition
may alter the epigenome of these young animals (Waterland et al.
2006).
Besides experimentally diet-mediated imprinting, general en-
vironment conditions may also lead to epigenetic variations in
humans. As another evidence of environment modification of the
epigenome, is the following study of Fraga and collaborators
(Fraga et al. 2005). From a set of monozygotic twins of various
ages and living in different environments, an epigenetic profile of
each person was performed by measuring the global CpG methy-
lation and the acetylation on H3 and H4 histones. This showed
that, although twins are epigenetically indistinguishable during
the early years of life, older twins exhibit remarkable differences
in their overall content and genomic distribution of DNA methyla-
tion and histone acetylation, which can thus bring variations in
each subject’s gene expression pattern. Furthermore, these data
clearly showed a more important difference of the epigenome
between older twins and between twins who have lived separately
more than 50% of their lifetime (Fraga et al. 2005).
Epigenetic modifications can therefore be induced by natural
and synthetic chemicals present in the environment. These epi-
genetic changes seem to lead to some genetic programs varia-
tions and consequently may have drastic effects on human
development and health. Amongst organs that can be affected by
these compounds, the reproductive tract is a very sensitive target.
The following paragraphs will address the developmental alter-
ations of the reproductive tract, which can be triggered by natural
and synthetic epigenetic effectors.
Effects of estrogens on female reproductive tract develop-
ment
As mentioned earlier, the development of the female reproduc-
tive tract (FRT) is regulated by steroid hormones and in particular
by oestrogens acting through two different receptors, designated
ERα and ERβ. ERα is predominantly expressed in the uterus,
vagina, mammary gland, and thecal cells of the ovary whereas
ERβ is mainly expressed in the granulosa cells of the ovary (Couse
and Korach 1999; Muramatsu and Inoue 2000). The particular role
of ERα in FRT development has been revealed by disrupting the
corresponding gene in the mouse, driving to hypoplastic uterine
and vaginal tissues (Couse and Korach 1999; Hewitt and Korach
2002).
The molecular mechanism triggered by steroid hormones is
relatively well known. Indeed, the steroid hormones linked to
specific nuclear receptors which are able to bind to the promoter of
target genes and then regulate proliferation and/or differentiation
processes (Groothuis et al. 2007). Considering the importance of
steroid hormones in FRT development, exposure to endocrine
disruptors may thus have a strong impact on this organ system. As
a matter of fact, aberrant temporal or over stimulation of oestrogens
signalling pathway during development is now known to lead to
various long-term or irreversible abnormalities (Newbold et al.
1990). During the last decades, large quantities of various chemi-
cals with oestrogenic activity have been released into the environ-
ment. Many of them can potentially influence the endocrine system
and therefore modify organs responsiveness to endocrine signals
during pre- and/or post-natal life, by disrupting the proper expres-
sion of oestrogen-regulated genes.
Amongst these compounds, genistein, a nonsteroidal
phytoestrogen, is present in food, particularly in soy products.
Human foetuses may thus be exposed to this molecule during in
utero development as well as in infancy through lactation. Newbold
and colleagues have demonstrated that neonatal exposure of mice
to genistein leads to an increase of uterine adenocarcinoma later
in life (Newbold et al. 2001). Moreover, this phytoestrogen can
exert dose-dependent adverse effects on the ovary: neonatal
exposure to genistein at environmentally relevant doses alters
ovarian differentiation and development, and leads to multioocyte
follicles still visible later in life; at a higher dosage, females become
infertile (Jefferson et al. 2002). In addition, at lower doses, females
show minor rates of pregnancy coupled with smaller and fewer
implantation sites (Jefferson et al. 2002).
Bisphenol A (BPA) is a synthetic compound used in the manu-
facture of many plastics including food containers and dental
composites. This molecule presents an oestrogenic activity and as
such, is able to induce malformations of the FRT. Indeed, recent
experimental studies on mice have highlighted the association of
BPA with deformity of the reproductive tract and with gynaecologic
cancers. In particular, it has been reported that exposure to BPA
leads to earlier vaginal opening (Honma et al. 2002), to altered
ovarian morphology (Markey et al. 2003; Kim et al., 2009), to
proliferative lesions of the uterus (Newbold et al. 2007a) and to a
strong incidence of cystic ovaries (Newbold et al. 2007a).
The most dramatic report on FRT malformations induced by a
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synthetic nonsteroidal estrogen-mimetic molecule, is the abnor-
malities observed in women exposed in utero to DES. Although,
this chemical had been demonstrated to be ineffective as soon as
1953 (Dieckmann et al. 1953), it was prescribed for miscarriage
and other pregnancy complications between 1938 and 1971.
Several studies have demonstrated that prenatal exposure of
female to DES was associated with subsequent development of
reproductive tract abnormalities. First, women prenatally exposed
to DES presented with a "T shaped" uterus and an increased
incidence of clear cell adenocarcimas of the vagina and cervix.
Second, these women also presented an enhanced risk of spon-
taneous abortion, ectopic pregnancy and preterm delivery (Kaufman
et al. 2000). These epidemiologic studies were corroborated by
experimental studies performed on mice exposed to DES during
development. Indeed, these mice showed many malformations of
the uterus, characterized by squamous metaplasia of the luminar
and glandular epithelium, and by endometrial hyperplasia and
increased risk of leiomyomas (Kitajewski and Sassoon 2000). In
addition, these mice showed persistent epithelium cornification of
the vagina associated with adenocarcinoma, and oviduct prolifera-
tive lesions (Mclachlan et al. 1980; Couse et al. 2001; Couse and
Korach 2004).
The overall data cited above demonstrate clearly that natural or
synthetic compounds, with oestrogenic activity, can have adverse
effects on the FRT and consequently disrupt reproductive func-
tions. Moreover, the detrimental effects of steroid disruptors are
generally not visible before the offspring reaches maturity or even
middle age. Such molecules have been shown to have long time
effects on the female mouse or woman reproduction. Indeed
epidemiologic and experimental studies have pointed out that
developmental alterations of the reproductive tract could be inher-
ited to the next generation, suggesting that DES exposure could
affect durably gene regulation. However, the molecular mecha-
nisms involved in such inheritance of altered genetic traits are far
to be clearly understood.
Effects of DES on developmental genes
As a first step to understand the molecular mechanisms in-
volved in the alteration of the female reproductive tract exposed to
DES, target genes for such molecules need to be clearly identified.
Amongst these genes, the Hoxa genes are under control of both
oestrogen and progesterone (Ma et al. 1998). Moreover, the
phenotype associated with developmentally experimental expo-
sure to DES is similar to those observed in Hoxa genes knocked out
mice. In fact, DES-induced abnormalities include loss of the
boundary between the oviduct and the uterus, associated with a
loss of uterotubal junction, a phenotype also present in Hoxa-10
mutant mice. Ma and collaborators have demonstrated that ex-
pression of Hoxa9, Hoxa10 and Hoxa11 is repressed by DES in the
mouse developing reproductive ducts following foetal or neonatal
exposure to DES (Ma et al. 1998). This repression of Hoxa genes
provides a putative explanation to the teratogenic effects of DES on
the developing FRT. Other features of DES exposure, i.e. vaginal
adenosis, abnormal urethral openings in the vagina and failure of
distal MD to form a common cervical canal, correlate with those of
the Hoxa-13 mutant mice. In order to further correlate DES expo-
sure and Hoxa genes expression, Block and collaborators, have
treated mice with DES from days 9 to 16 of gestation (Block et al.
2000). Using in situ hybridization experiments, they revealed a
posterior shift of Hoxa9 and Hoxa10 expression in the reproductive
tract of female offspring. A similar decrease was observed in the
Hoxa11 anterior expression domain. In this study, the authors
suggested that the DES-induced homeotic transformations of the
reproductive tract could correspond to the uterine morphological
changes seen in up to 70% of the women exposed in utero to DES
(“T-shaped” uterus). In fact, the decrease of Hoxa10 and Hoxa11
expression and the increase of Hoxa9 expression may cause the
uterus to develop in the tissue normally fated by Hoxa9 i.e. the
oviduct. The T-shape of the uterus in DES-exposed women, may
then stand for a transformation into an oviduct-like structure (Block
et al. 2000).
In addition to these studies on Hox genes, other investigations
have shown that DES is acting through multiple gene pathways to
cause structural changes in the FRT. For instance, DES in utero
exposure leads to a down-regulation of the Wnt7a gene in the foetal
uterus up to birth; normal regulation of the gene is only restored 5
days after birth (Miller et al. 1998a). Interestingly, prenatally DES-
exposed mice and Wnt7a-/- mutants show similar deformity of the
FRT. One hypothesis to explain this, would be that the DES-
induced transient down-regulation of Wnt7a during a critical win-
dow of time, is sufficient to account for the DES syndrome. During
the down-regulation of the Wnt7a gene, the female reproductive
tract would lose the competency to respond appropriately to
surrounding signals. This hypothesis is consistent with grafting
experiments showing that vaginal and uterine epithelia are respon-
sive to stromal induction when grafting is performed between P3 to
P5. It is noteworthy that epithelia are no more responsive when the
experiment is performed at later stages (Cunha 1976b).
The expression of the developmental gene Msx2 has also been
described to be altered in the female reproductive tract following
foetal exposure to DES. Indeed, Msx2 is involved in vaginal
epithelial differentiation and is required for Tgf-β2 and -β3 expres-
sion in the reproductive tract (Yin et al. 2006). In mice, after
exposure to DES, the level of Msx2 transcripts is significantly lower
than physiological level in the developing uterus (Huang et al.
2005) and in vaginal epithelium (Yin et al. 2006). Moreover, a much
more severe DES-induced vaginal phenotype is observed in Msx2-
/- mutant mice exposed to DES, suggesting an important role for
this gene during the estrogen-dependent growth of Müllerian
derivatives and therefore in the protection of adverse effects of
DES (Yin et al. 2006). However this protective mechanism remains
unknown.
Many developmental genes involved in organogenesis of the
FRT have been shown to be deregulated following in utero or
neonatal exposure to the pharmacological endocrine disruptor
DES. In spite of this, the mechanism by which these deregulations
would be transmitted through generations is completely unclear.
Indeed, no alteration of genomic DNA methylation pattern has
been described yet under this condition. In particular, no variation
in the methylation pattern of Hoxa10 and Hoxa11 promoters was
observed in the mouse uterus after neonatal DES exposure (Li et
al. 2001a). This transmission of phenotypic traits without alteration
of methylation marks on DES-regulated genes is thus extremely
puzzling and needs to be clarified.
DES and epigenetics
During more than 30 years, DES was heavily prescribed to
pregnant women to prevent miscarriages and other pregnancy
420    J. Massé et al.
problems. Much later, correlation between this chemical com-
pound and reproductive dysfunctions was uncovered. Epidemio-
logic studies revealed that structural uterine, cervical or vaginal
abnormalities may be as high as 33% in women with in utero
exposure and that overall pregnancy outcomes in DES-exposed
women were worse than those in unexposed women (Kaufman et
al. 2000). Moreover, a small cell ovarian carcinoma was found in
a 15 year old girl whose maternal grand mother was treated by
DES during her pregnancy (Blatt et al. 2003).
This observation was later established in the mouse, in experi-
ments aiming at understanding genetic and epigenetic mecha-
nisms involved in both adverse and transgenerational effects of
DES exposure. Overall outcomes showed that foetal exposure to
DES led to poor reproductive outcome and to gynaecologic
tumours later on. Furthermore, it appeared that the adverse
effects of DES, such as tumour susceptibility, could be transmit-
ted to subsequent generation (s) of both males and females. More
precisely, experiments dealt with mice exposed to DES during
various stages of gestation and with F1 and F2 females mated to
unexposed males. It first appeared that F2 females’ fertility was
not affected unlike F1’s. However F2 mice showed a high fre-
quency of tumours, about similar to that assessed in F1 (Walker
and Haven 1997). This study was further corroborated although
F2 females exhibited a tumour incidence (including uterine ad-
enocarcinoma) higher than controls but lower than F1 mice
(Newbold et al. 1998).
The transmission of specific lesions of the female reproductive
tract, such as uterine adenocarcinoma, to subsequent
generation(s) seems to be difficult to explain without evoking
epigenetic mechanisms. While no epigenetic modification was
detected on key developmental genes such as Hoxa genes (Li et
al. 2001b), modifications of DNA methylation have been reported
for other genes following exposure to DES (Newbold et al., 1997;
Tang et al., 2008). For example the estrogen-responsive lactoferrin
gene seems to be up-regulated in the mouse uterus, after neona-
tal exposure to DES; this abnormal expression persists later in life
(Nelson et al. 1994) and may be attributed to an abnormal
demethylation in the lactoferrin gene promoter, which seems to
occurr specifically in response to neonatal DES exposure (Li et al.
1997). Moreover, this demethylation state is continuously main-
tained in uterine tumours of DES-exposed mice, suggesting that
neonatal DES treatment may not only induce tumour formation
but also gene-specific demethylation, through a common cellular
process, such as alterations of the expression of DNA
methyltransferases and methylation of genomic DNA (Li et al.
1997; Sato et al. 2009). Subsequent work demonstrated that
other developmental genes, up-regulated after exposure to DES,
also exhibit modified methylation patterns. As such, the proto-
oncogene c-fos is one of the early and persistently induced genes
in uterine epithelium of mice exposed to oestrogen stimulation
(Loose-Mitchell et al. 1988). Moreover this gene is known to play
an important role in uterine epithelial proliferation and in uterine
tumorigenesis. As a matter of fact, the yield of unmethylated
CpGs in the exon-4 of this gene, is higher in neonatally DES-
exposed mice than in untreated controls (Li et al. 2003). Although,
the consequences of the hypomethylation level of these two
genes remain unclear, it has been proposed that methylation
pattern of genomic DNA can be transmitted to subsequent gen-
eration (s) (Holliday 1990). The fact that F2 mice, which were not
directly exposed to DES, develop uterine adenocarcinoma would
thus be explained by the transmission of modified methylation
pattern of genes involved in cell homeosis such as the proto-
oncogene c-fos. In addition, we previously mentioned, that
genistein was a compound presenting an oestrogenic activity,
and able to induce formation of multioocyte follicles on DES-
treated neonates (Jefferson et al. 2002). Interestingly, a comple-
mentary study showed that F2 female mice also present multioocyte
follicles although they were not formerly exposed to genistein
(Jefferson et al. 2007).
The transmission of epigenetic pattern has been difficult to
accept for many scientists until recently. Indeed, for several
years, it was thought that methylation prints were removed from
DNA as it was packaged into germ cells, wiping the epigenetic
state clean for next generation. The whole literature on DES, as
well as other studies performed by Cropley and collaborators,
strengthen the relevance of a transmission of the epigenome
through following generations (Cropley et al. 2006). Indeed, these
authors showed that feeding pregnant Avy/a mice with methyl
donor in their diet not only shifted the coat colours of their offspring
towards the brown end of the spectrum (Wolff et al. 1998), but also
affected the next generation in the same way, showing that the
grandmother’s diet can affects the epigenetic state of her grand-
children (Cropley et al. 2006) through a stable modification of the
germline epigenetic state (Cropley et al. 2007).
Conclusion
The venue of epigenetic research has allowed scientists to
interpret some inexplicable malformative pathologies or environ-
mental induced diseases such as cancers or allergies. Indeed,
epigenetics could explain not only the discordances observed
between monozygous twins but also phenomena such as incom-
plete penetrance, variable expression, sporadic cases and pro-
vide a novel viewpoint for understanding normal and aberrant
development. The study of epigenetic mechanisms involved in
such normal and pathologic processes constitutes thus a new
exciting approach of investigation. In addition, considering that
most epigenetic alterations are reversible both in vitro and in vivo,
it suggests that a new therapy targeting complexes that catalyse
epigenetic modifications could be found in the future.
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